Cargando…
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery
BACKGROUND: Parkinson’s disease is a disorder growing in prevalence, disability, and deaths. Healthcare databases provide a ‘real-world’ perspective for millions of individuals. We envisioned helping accelerate drug discovery by using these databases. OBJECTIVES: The objectives of this study were to...
Autores principales: | Cepeda, M. Soledad, Kern, David M., Seabrook, Guy R., Lovestone, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800403/ https://www.ncbi.nlm.nih.gov/pubmed/31327127 http://dx.doi.org/10.1007/s40261-019-00830-4 |
Ejemplares similares
-
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications
por: Kern, David M., et al.
Publicado: (2019) -
Treatment with TNF‐α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease
por: Kern, David M., et al.
Publicado: (2021) -
Treatment patterns of patients diagnosed with major depressive disorder and suicidal ideation or attempt: a U.S. population-based study utilizing real-world data
por: Kern, David M., et al.
Publicado: (2021) -
Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists
por: Kern, David M., et al.
Publicado: (2021) -
The Ultimate Guide to Strategic Marketing: Real World Methods for Developing Successful, Long-term Marketing Plans
por: Hamper, Robert
Publicado: (2013)